Document Detail

Posaconazole for chronic pulmonary aspergillosis: the next strategy against the threat of azole-resistant Aspergillus infection.
MedLine Citation:
PMID:  21054178     Owner:  NLM     Status:  MEDLINE    
Shigeru Kohno; Koichi Izumikawa
Related Documents :
24371558 - Snapshot of spatio-temporal cytokine responses to single and co-infections with helmint...
23684568 - Impact of schistosoma mansoni and echinococcus granulosus experimental coinfection on i...
23809748 - Cytomegalovirus infection and cervical cancer: from past doubts to present questions.
23135938 - Sonication versus vortexing of implants for diagnosis of prosthetic joint infection.
23335588 - A systematic review of validation studies of the use of administrative data to identify...
23602428 - Immune surveillance mechanisms of the skin against the stealth infection strategy of ps...
Publication Detail:
Type:  Comment; Editorial     Date:  2010-11-05
Journal Detail:
Title:  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America     Volume:  51     ISSN:  1537-6591     ISO Abbreviation:  Clin. Infect. Dis.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-18     Completed Date:  2011-02-25     Revised Date:  2013-11-25    
Medline Journal Info:
Nlm Unique ID:  9203213     Medline TA:  Clin Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1392-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antifungal Agents / therapeutic use*
Aspergillus / drug effects*
Drug Resistance, Fungal*
Pulmonary Aspergillosis / drug therapy*
Treatment Outcome
Triazoles / therapeutic use*
Reg. No./Substance:
0/Antifungal Agents; 0/Triazoles; 6TK1G07BHZ/posaconazole
Comment On:
Clin Infect Dis. 2010 Dec 15;51(12):1383-91   [PMID:  21054179 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Rearrest after prehospital resuscitation.
Next Document:  Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.